http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009157858-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfef4bf7e1708975cb1ce488e3a1564b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09b75447599077b3bb8729d973ebb411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26cb4433b78031ff77fb3e072e5d4038
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
filingDate 2009-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcec3860739a59d6bb8f6382a0b00999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cacc41c187f1794002a0fecedc717126
publicationDate 2010-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009157858-A8
titleOfInvention Use of cyclolignans for the treatment of a hyperactive immune system
abstract There is disclosed use of certain picro derivatives of cyclolignans for prophylaxis or treatment of diseases or conditions characterised by a hyperactive immune system. Examples of cyclolignans according to the invention include picropodophyllin, deoxypicropodophyllin, anhydropicropodophyllol or deoxyanhydropicropodophyllol. Formula (I)
priorityDate 2008-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226523076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11711021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227240044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226523077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415946347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID345501

Total number of triples: 40.